6, which may contribute to the pathology of the infection. In vitro CMV induction of IL-6 by human lung fibroblasts was studied. The quantity of cytokine in culture supernatants was maximal 20 h after infection and decreased thereafter. Transcription of the IL-6 gene and IL-6 protein expression were equally stimulated by infectious and UV-inactivated virus (CMV-UV). CMV-UV-stimulated IL-6 was inhibited by pyrrolidinedithiocarbamate (an inhibitor of the transcription factor, NF-kB) and by pertussis toxin (suggesting the involvement of a G protein) and occurred in the absence of CMV immediate-early antigen transcription. Neutralizing antibodies to IL-1b or tumor necrosis factor-a did not affect CMV-UV-induced IL-6, but expression was inhibited by antibody to the CMV attachment glycoprotein. IL-6 production by fibroblasts occurs independently from productive infection but has characteristics that suggest a ligand receptor-mediated pathway. This function may be important in pathology or disease resolution.
development of posttransplant lymphoproliferative disease among liver transplant recipients [6] .
These unique consequences of CMV infection may be due to the ability of this virus to modulate the immune system of the host. CMV infection has been shown to induce cytokine production by several cell types. Important among these is interleukin (IL)-6. IL-6 is a cytokine that promotes inflammation by stimulating the production of acute-phase reactants by the liver and by stimulating the proliferation of B and T lymphocytes and bone marrow precursor cells [7] . It is possible that IL-6 production during infection contributes to the above-described CMV-related pathologic processes. In support of this hypothesis, the rejection of allografts has been shown to be accompanied by increased graft mRNA and serum levels of IL-6 [8] [9] [10] . In addition, IL-6 has been identified in atherosclerotic plaque [11] and regulates serum amyloid A [12] , which has been associated with primary and posttransplantation graft atherosclerosis [13, 14] .
Given the significant biologic and pathoetiologic functions of IL-6, we chose to study the effects of CMV infection on human lung diploid fibroblasts, with respect to this cytokine.
Methods
Virus. Human CMV (Davis strain) was obtained from the American Type Culture Collection (Rockville, MD). Virus was propagated in low-passage MRC-5 human diploid fetal lung fibroblasts. The MRC-5 cultures were maintained in Eagle MEM with nonessential amino acids; 50 U/mL penicillin; 50 mg/mL streptomycin, gentamicin, and amphotericin B; 10 mM HEPES; 5% fetal calf serum; and 7.5 mM sodium bicarbonate. Infected cells were lysed by three freeze-thaw cycles, and the cell lysates clarified by centrifugation. Infectious virus in the supernatant was quantified by determining the TCID 50 . Replicate cultures ( ) were inn ϭ 12 oculated with serial logarithmic dilutions of the supernatant. The cultures were monitored for the development of characteristic cytopathic effect (CPE), and the dilution of supernatant producing CPE in 50% of the replicate cultures was determined by interpolation. The stock CMV preparation was determined to contain 10 4.2 TCID 50 .
UV inactivation. CMV was inactivated by exposure to a 254-nm germicidal UV lamp at a distance of 8 cm for 30 min (CMV-UV).
mRNA extraction. For total RNA extraction, RNAzol B (TelTest, Friendswood, TX) was used. Briefly, cells were homogenized in a tissue homogenizer with 2 mL of RNAzol B; 0.2 mL of chloroform was added to the homogenate, and the mixture was held on ice for 5 min, followed by sedimentation at 12,000 g at 4ЊC. RNA was precipitated by combining the aqueous phase with an equal volume of isopropanol; the precipitate was recovered by centrifugation (12,000 g at 4ЊC), washed once in 75% ethanol, and solubilized in diethylpyrocarbonate (DEPC)-treated water. To remove possible genomic DNA contamination, the RNA preparation was treated with 50 U/mL DNase for 30 min at 37ЊC; the DNase was inactivated by heating to 95ЊC for 5 min.
Reverse transcription. Extracted RNA (3 mg) was diluted in 10ϫ amplification buffer (Perkin-Elmer, Norwalk, CT) with 25 mM dNTPs, 20 mM dithiothreitol, 200 U/mL Moloney murine leukemia virus reverse transcriptase (Promega, Madison, WI), 50 mM magnesium chloride, and 100 pmol/mL random hexamers (Promega) and brought to a final volume of 20 mL with DEPC-treated water. The mixture was incubated at 37ЊC for 30 min and then held at 95ЊC for 5 min to inactivate the reverse transcriptase.
Polymerase chain reaction (PCR). cDNA sequences generated by reverse transcription were amplified by PCR. The following primer sequences were used to amplify the IL-6 cDNA [15] : upstream, 5 -CAAAAGTCCTGATCCAGTTCC-3 ; downstream, 5 -ACATAATTTCTGTGCCCAGTG-3 . Reverse transcription products (5-10 mL) were added to a reaction tube containing 5.0 mL of 10ϫ amplification buffer, 4.0 mL of 2.5 mM dNTPs, 5.0 U of Taq polymerase (Promega), 2.5 mL of a 20 mM solution of each primer, and DEPC-treated water, to a total volume of 50 mL. The amplification protocol consisted of 30 cycles of a 94ЊC denaturation segment, a 55ЊC annealing segment, and a 72ЊC extension segment. A final extension at 72ЊC was included after the last cycle. The primers and amplification protocol for the CMV major immediateearly (IE) antigen gene have been previously described [16] . After amplification, the products were visualized by electrophoresis through a 2% agarose gel, staining with 1 mg/mL ethidium bromide, and illumination with a UV lamp.
IL-6 measurement. The production of IL-6 by MRC-5 cultures was determined by ELISA (Quantikine Immunoassay; R&D Systems, Minneapolis) according to the manufacturer's recommendations. Results are presented as optical density (OD) measured at 450 nm (A 450 ) of the colored product generated by the enzymatic conversion of the colorless substrate (tetramethylbenzidine) by a conjugate of horseradish peroxidase and anti-IL-6. Results are given as the of 3 replicates at each test point. mean ‫ע‬ SE Chemicals. Pyrrolidinedithiocarbamate (PDTC) and pertussis toxin (PT) were obtained from Sigma (St. Louis).
Neutralizing antibodies. Anti-CMV gpUL55 antibody was obtained from Advanced Biotechnologies (Columbia, MD) and diluted to a final concentration in tissue culture medium. CMV-UV was mixed with the antibody and incubated for 2 h at 37ЊC. After incubation, the antibody-treated virus was added to microwells containing freshly washed MRC-5 cells. The cultures were incubated for 24 h and the supernatants collected for IL-6 assay. Anti-IL-1b and anti-tumor necrosis factor (TNF)-a were obtained from R&D Systems. MRC-5 cells were challenged with a 10 Ϫ2 dilution of CMV-UV in the presence of antibody ranging in concentration from 0.25 to 100 mg/mL. The cultures were incubated for 24 h, and IL-6 in the supernatant was measured.
Statistical analysis. Comparisons between experimental points were done with Student's t test for unpaired data.
Results

IL-6 production induced by CMV-infected cells and cells treated with CMV-UV.
CMV has been found to induce IL-6 in a variety of cell types. We initially tested the ability of CMV to induce IL-6 production by fresh MRC-5 cell cultures. Cells were trypsinized and cultured for 24 h, at which time fresh medium containing a 10 Ϫ1 dilution of virus stock or the same dilution of a sham viral preparation from uninfected cells was added. Supernatants were harvested following an additional 24-h incubation. Means and SEs of the OD measurements were generated by IL-6-specific ELISA of the supernatants of three replicate cultures at each experimental point. We observed a 4-fold increase in IL-6 production in CMV-treated cells (A 450 ), compared with untreated MRC-5 cultures (A 450 0.654 ‫ע‬ 0.05 ; ) or MRC-5 cultures treated with the sham 0.16 ‫ע‬ 0.05 P ! .002 viral preparation (A 450 ; , unpaired t test). 0.20 ‫ע‬ 0.03 P ! .01 To determine whether infectious virus is required to stimulate IL-6 production, an aliquot of the virus preparation was subjected to UV irradiation. CMV-UV was tested on fresh 24-h MRC-5 cultures as above and compared with infectious virus. The results of this experiment are shown in figure 1. UV irradiation did not abrogate the ability of CMV to induce IL-6 production. Greater than 7-fold increases in IL-6 quantities were produced by MRC-5 cells treated with 10 Ϫ1 and 10 Ϫ1 dilution of infectious virus exceeded the measurable limits; for statistical purposes, a nominal value of 2.0 was assigned to these values, and statistical analysis was done with the Mann-Whitney U test. Both the 10 Ϫ1 and 10 Ϫ2 dilutions of CMV-UV produced IL-6 in quantities much greater than did control cells ( , Mann-P ! .04 Whitney).
Dilutions of the virus (both UV-irradiated and untreated)
110
Ϫ2 failed to stimulate IL-6 production. The ability of the Ϫ2 dilution of infectious virus were immeasurable (12.0); for these experimental points, means were estimated using nominal value of 2.0. SEs were not calculated; statistical analysis of these data used nonparametric Mann-Whitney U test. UV irradiation protocol to render CMV noninfectious was verified by (1) the failure to detect CMV IE antigen by immunofluorescence staining in shell-vial cultures challenged with UV-treated virus, (2) the failure of CMV-UV to produce characteristic CMV CPE in tube cultures, and (3) the inability to detect CMV IE antigen mRNA in cell cultures treated with irradiated virus stock. Nonirradiated virus from infected cells proved positive for infectious virus by all three of these assays.
Of interest, replicate cultures ( ) were infected with logn ϭ 12 arithmic dilutions of the infectious virus, and the presence of characteristic CPE was scored after 7 days; supernatant IL-6 was measured after 24 h. Virus infectivity was seen at several dilutions beyond the end point for stimulation of IL-6 production. As previously seen, no IL-6 production was stimulated by virus diluted beyond 10 Ϫ2 . However, 100% of the replicate cultures at the 10 Ϫ3 dilution showed 7-day CPE, 83% were infected by the 10 Ϫ4 dilution, and 25% by the 10 Ϫ5 dilution. These experiments demonstrate that there are differences in the kinetics of cellular events that lead to productive viral infection versus those that lead to IL-6 expression. This finding putatively suggests the involvement of two distinct pathways leading to these respective end points. This hypothesis would also explain the observation that UV-inactivated virus is as efficient in the stimulation of IL-6 production as is infectious virus.
Kinetics of IL-6 production in MRC-5 cultures. The time course of IL-6 production induced by CMV-UV (10 Ϫ2 dilution) in MRC-5 cultures is presented in figure 2 . A significant elevation of IL-6 in the supernatants of CMV-UV-treated MRC-
IL-6 transcription following treatment of fibroblasts with CMV and CMV-UV.
Experiments were performed to determine whether treatment of MRC-5 cells with CMV (or CMV-UV)-induced transcription of the IL-6 gene mRNA was isolated from cells 24 h after treatment with a 10 Ϫ1 dilution of either infectious CMV or CMV-UV. The mRNA was reverse-transcribed, and the cDNA was amplified by PCR. The amplified products were detected by agarose electrophoresis and staining with ethidium bromide. As presented in figure 3A , increased transcription of the IL-6 gene over levels in control cells was evident for cells treated with either infectious CMV or CMV-UV. DNase treatment of the mRNA preparations prior to cDNA synthesis ensured that the results were not due to contaminating genomic DNA. These results further substantiate the hypothesis that CMV-UV induces the cytokine via a mechanism that is distinct from the normal mode of infection.
The treated cells were also examined for the presence of mRNA transcribed from the CMV major IE antigen gene. This was done to confirm the absence of infectious virus in the CMV-UV preparation and also to test a previously stated hypothesis that IL-6 production in CMV-infected cells is under the regulation of the products of the CMV IE genes [17] . Our results (figure 3B) indicated that CMV major IE mRNA was present in cells treated with infectious virus. In contrast, CMV-UV did not contain CMV major IE message. These findings, in conjunction with our observation that strong IL-6 message was found in cells treated with both infectious CMV and CMV-UV, indicate that IL-6 transcription occurred in the absence of CMV major IE transcription and is not dependent on prior CMV major IE gene transcription or infectious virus.
NF-kB and G protein requirement for stimulation of IL-6.
Transcription factor NF-kB is critical in the inducible expression of numerous cellular genes. Of particular interest is the dependence of proinflammatory cytokine gene transcription on the availability of this factor. Thus, we sought to determine whether the antioxidant inhibitor of NF-kB activity, PDTC, would prevent the production of IL-6 in response to CMV-UV. MRC-5 cell cultures were stimulated with a 10 Ϫ2 dilution of CMV-UV in the presence of various concentrations of PDTC. The cultures were incubated for 24 h and the quantities of IL-6 determined. As presented in figure 4 , treatment of cells with CMV-UV stimulated the production of large quantities of IL-6 (A 450 vs. for control cells; , 3.12 ‫ע‬ 0.12 0.20 ‫ע‬ 0.27 P ! .001 unpaired t test). Addition of 1000 mM PDTC to the cultures reduced the IL-6 production ∼10-fold (A 450 ); a 0.35 ‫ע‬ 0.018 dose-response effect was observed between the concentration of PDTC and the degree of inhibition of IL-6 production ( , , by linear regression), but IL-6 was signif-
icantly reduced at all concentrations tested ( , unpaired P ! .001 t test). These findings suggest that the CMV-mediated stimulation of IL-6 production in fibroblasts is mediated through the activation of NF-kB.
By using a smooth-muscle model to study intracellular signaling following infection with CMV, Shibutani et al. [18] also observed that CMV infection in these cells activates NF-kB. In their experiments, NF-kB activation occurred as a downstream event in a cascade that contained a PT-sensitive step upstream from NF-kB activation. Thus, we also wished to determine whether, in our model, the production of IL-6 was sensitive to PT. MRC-5 cells were preincubated for 2 h with decreasing concentrations of PT. The cells were treated with a 10 Ϫ2 dilution of CMV-UV, and the supernatant concentration of IL-6 was determined after a 24-h incubation (figure 5). Cultures incubated with 125 ng/mL PT showed a significant reduction (A 450 ) compared with CMV-UV-treated cells (A 450 1.75 ‫ע‬ 0.23 ;
). An even greater reduction was seen for 3.12 ‫ע‬ 0.16 P ! .005 cells treated with 250 ng/mL PT (A 450 ; , 1.44 ‫ע‬ 0.11 P ! .001 unpaired t test). These findings are consistent with the hypothesized presence of a G protein in the signaling pathway leading to IL-6 production.
Effects of neutralizing antibodies to IL-1, TNF-a, and CMV gpUL55 on the production of IL-6 by CMV-UV-stimulated cells.
Previous studies have shown that the virus-free supernatant from CMV-infected cells could stimulate IL-6 production, suggesting that a cytokine or similar soluble mediator could be responsible for the observed results [19] . IL-1b and TNF-a are known stimulators of IL-6 in a number of cell types. In addition, they have been shown to activate NF-kB via their specific receptors. Therefore, we wished to eliminate these cytokines, which were possibly contaminating our virus preparation, as a cause of our findings. Neutralizing antibodies to these cytokines were added to CMV-UV-treated cultures in concentrations ranging from 0.25 to 100 mg/mL, and the IL-6 production was measured. Neither antibody at any concentration tested decreased IL-6 production measurably (data not shown). These antibody blocking experiments eliminated IL1b and TNF-a as the stimulators of IL-6 production in this model system.
We also tested the ability of antibody to gpUL55, a viral glycoprotein that mediates attachment of CMV to target cells [20] , to block IL-6 production. A 1:10 dilution of CMV-UV was incubated with 3 mg/mL neutralizing antibody at 37ЊC for 2 h. Following incubation, 20-mL aliquots were dispensed into microwells containing cells in 0.2 mL of fresh tissue culture medium. The cultures were incubated for 24 h and the quantity of IL-6 determined. The antibody-treated cultures showed a significant reduction of IL-6 production (A 450 ), 0.432 ‫ע‬ 0.23 compared with untreated cultures (A 450 ; 0.890 ‫ע‬ 0.009 P ! ). Because the blocking of gpUL55 with antibody is be-.001 lieved to prevent viral attachment to the fibroblasts, the reduction of IL-6 production by this antibody strongly implicates the attachment of the CMV-UV to a fibroblast receptor as an essential step in this process.
When viewed together, the results of our experiments indicate that challenge of human lung fibroblasts with CMV induces a rapid (peaking within 24 h) transcription and release of IL-6; the process does not require infectious virus and occurs independently of the transcription of the CMV major IE genes. Moreover, the sensitivity of IL-6 production to G protein and NF-kB inhibitors and the blocking of IL-6 production by antibody to the CMV attachment structure, gpUL55, provide evidence that this phenomenon is mediated through an intracellular signaling cascade linked to an as-yet-unidentified cellular receptor for which CMV gpUL55 is a ligand.
Discussion
CMV infection (both in vivo and in vitro) has been shown to induce IL-6, and IL-6 has been associated with pathology in a number of CMV-related disease states. The present study was undertaken to explore the phenomenon of IL-6 production by human lung fibroblasts following infection with this virus. Our initial observation was that CMV infection of fibroblasts and challenge of fibroblasts with CMV-UV both result in a rapid production of IL-6 that was measurable in the cell culture supernatant. Although multiple mechanisms could (and probably do) contribute to cytokine production, we attempted to examine the mechanism(s) through which CMV-UV mediates this effect in the absence of productive viral infection.
Previous investigators have identified several physiologic responses of cultured cells to CMV infection; these responses include the up-regulation of adhesion molecules and the production of cytokines. Craigen and Grundy [21] observed the up-regulated expression of intercellular adhesion molecule 1 (ICAM-1, CD54) and leukocyte function-associated antigen 3 (LFA-3, CD58) on fibroblasts following in vitro infection. Other investigators demonstrated that in vitro challenge of human endothelial cells with CMV resulted in the production and release of IL-6 [19] . In all of these experiments, the observed effects were abrogated by UV inactivation of the virus. Thus, these phenomena were thought to be related to the infectious process. In the present investigation, however, we observed the production of IL-6 to be equally stimulated by infectious or UV-inactivated CMV. A similar observation was made for transcription of the IL-6 gene. It is doubtful that the observed effect could have been due to residual infectious virus, because the inactivated viral preparation failed to produce characteristic CPE in MRC-5 fibroblasts. In addition, when target cells were challenged with CMV-UV, there was no transcription of the major IE antigen gene and no production of the major early protein. Thus, IL-6 gene transcription and the accumulation of the cytokine in the culture supernatant do not require productive infection in this model, although an extracellular virus particle activating an unknown receptor via gpUL55 appears to be part of the signaling pathway. Whether a latent CMV infection without the production and release of virus particles would similarly stimulate IL-6 production is not addressed by these studies.
In our experiments, the CMV major IE antigen gene was not transcribed in MRC-5 cells challenged with CMV-UV. This observation derives significance from the fact that previous transfection experiments have shown that the products of CMV IE genes enhance the promoter activity of the IL-6 gene. In those experiments, the CMV IE gene products enhanced the reporter activity of an IL-6 gene promoter containing only an NF-kB binding element [17] . In contrast, we found IL-6 production to occur in the absence of CMV major IE transcription. However, we also found that IL-6 production was inhibited by the presence of PDTC, an antioxidant inhibitor of NF-kB activity. Taken together, these observations could suggest two convergent pathways, both requiring NF-kB activation but differing in their requirement for CMV major IE gene transcription.
In an earlier series of experiments, Almeida et al. [19] found that the ability to induce IL-6 was present in both purified infectious virus and the virus-free supernatants from CMVinfected cells. In the latter case, their findings suggest that soluble mediators released from CMV-infected cells act in an autocrine or paracrine manner to induce IL-6 production. Because our experiments were conducted with unpurified virus, the potential for contamination with such a mediator(s) was a possibility. We therefore tested whether IL-6 production could be reduced with neutralizing antibodies to IL-1b and TNF-a, two recognized stimulators of IL-6 production. Neither antibody, when included in MRC-5 cultures with CMV-UV, produced an observable reduction in IL-6. It was of interest, however, that pretreatment of CMV-UV with CMV gpUL55 neutralizing antibody effectively reduced IL-6 levels. These experiments exclude IL-1b and TNF-a as significant inducers of IL-6 in this model but suggest that the observed phenomenon is dependent on a ligand-receptor-like interaction between the viral gpUL55 glycoprotein and a fibroblast receptor.
The involvement of gpUL55 in a receptor-like activation leading to NF-kB activation has been described. Previous experiments [22] have demonstrated that ligation of cellular receptors by gpUL55 activate this transcription factor independently of viral infection. In our model, the production of IL-6 was dependent on both gpUL55 and NF-kB, consistent with these earlier observations. In addition, we found that the production of the cytokine was inhibited by PT, an inhibitor of G proteins. G proteins are a class of GTP/GDP-binding transmembrane proteins that are frequently associated with cellular receptors and function in transduction of signals to the cell transcriptional machinery. A G protein-NF-kB signaling pathway in CMV-infected smooth-muscle cells has been described [18] . Thus, we tested whether IL-6 production in fibroblasts challenged with CMV-UV possessed a G protein intermediate. In our experiments, PT reduced IL-6 production in a dosedependent manner, indicating the presence of a G protein in the CMV-IL-6 pathway. Thus, we found a similar signaling pathway for fibroblasts as previously reported for smooth-muscle cells.
Collectively, the present investigation of IL-6 up-regulation by human lung fibroblasts challenged with CMV-UV suggests a model in which the gpUL55-dependent ligation of an as-yetunidentified G protein-coupled receptor activates NF-kB, which induces the transcription of the IL-6 gene, with subsequent protein production and release. The blocking of IL-6 production by the antioxidant NF-kB inhibitor, PDTC, suggests the involvement of reactive oxygen intermediates in the signaling pathway, but this remains to be demonstrated. This proposed model will require confirmation but may eventually provide insight into a mechanism through which CMV can produce pathology. Alternatively, IL-6 production by cells shortly following viral attachment may provide an initial line of defense against the spread of this virus. The biologic significance of these observations with respect to disease causation or eradication and the ability to modify these events to the benefit of the infected individual will require additional investigation.
